# University of Virginia Cancer Center Support Grant

> **NIH NIH P30** · UNIVERSITY OF VIRGINIA · 2020 · $149,983

## Abstract

OVERALL – PROJECT SUMMARY/ABSTRACT
This application seeks renewed CCSG funding for the University of Virginia (UVA) Cancer Center, a matrix
cancer center that brings together 132 Members from 26 Departments in the Schools of Medicine, Nursing,
and Engineering, and in the College of Arts and Sciences. The UVA Cancer Center receives $25.96M from
NCI, $32.65M from other peer-reviewed sources, and $4.36M from non-peer-reviewed sources, for a total of
$62.97M in overall funding. Through faculty recruitment and robust infrastructure development, the UVA
Cancer Center has continued to build on its exceptional basic science foundations and has greatly enhanced
its ability to accelerate clinical and translational cancer focused research. Since the last renewal, over 50 new
faculty have been recruited, including twenty-four clinical investigators and/or physician-scientists and twenty-
six laboratory scientists, bioengineers, population, and computational biologists. The Cancer Center has five
Programs: Chemical and Structural Biology (CSB), Molecular Genetics and Epigenetics (GEN), Cancer Cell
Signaling (SIG), Immunology/Immunotherapy (IMM), and Women's Oncology (WON). This application requests
support for seven Shared Resources: Advanced Microscopy Facility (AMF), Animal Models of Disease Core
(AMDC), Biomolecular Analysis Facility (BAF), Bioinformatics Core (BIC), Biorepository and Tissue Research
Facility (BTRF), Biostatistics Shared Resource (BSR), and Flow Cytometry Core (FCC). In addition, we request
support for Clinical Protocol and Data Management (CPDM) infrastructure and a Protocol Review and
Monitoring System (PRMS). A completely transformed infrastructure for translational and clinical research
facilitates investigations using human tissues and the implementation of clinical trials. Substantial new
initiatives have been launched to reach underserved populations in Appalachia. This renewal application
describes continued outstanding basic cancer research, enhanced cancer focus, and greatly strengthened
clinical research leadership and infrastructure.

## Key facts

- **NIH application ID:** 10243690
- **Project number:** 3P30CA044579-29S4
- **Recipient organization:** UNIVERSITY OF VIRGINIA
- **Principal Investigator:** Thomas P. Loughran
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $149,983
- **Award type:** 3
- **Project period:** 1997-09-16 → 2022-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10243690

## Citation

> US National Institutes of Health, RePORTER application 10243690, University of Virginia Cancer Center Support Grant (3P30CA044579-29S4). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10243690. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*